Eligibility criteria do not
Approval timeline is estimated for late 2026 or 2027, making it unavailable for immediate use but worth watching closely
First, when it comes to Type 2 diabetes, these medications are incredibly effective
citeturn2news12 Safety and side effects Common side effects for GLP-1s include nausea, vomiting, diarrhea, constipation, and, less commonly, pancreatitis or gallbladder issues
PMCID: PMC6835556
Most common side effects of topiramate: The common side effects of topiramate include tingling in the arms and legs (paresthesia), drowsiness or fatigue, dizziness, nausea, difficulty with memory or concentration, and changes in taste